The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?
作者： Joshua Casaos , Noah L. Gorelick , Sakibul Huq , John Choi , Yuanxuan Xia
DOI: 10.1158/1535-7163.MCT-18-0666
关键词:
摘要: … In this review, we summarize the role of ribavirin as an antiviral … potential use and mechanisms of action of ribavirin in cancer. … Converging evidence suggests that ribavirin represents a …
aacrjournals.org
elsevier.com
sci-hub.se 参考文章(73)
Wolfgang Sadée, Huey-Jane Lee, Binh T. Nguyen, Katarzyna Pawlak, Roland K. Robins, Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture. Cancer Research. ,vol. 45, pp. 5512- 5520 ,(1985)
Takashi Honda, Masatoshi Ishigami, Hiroko Masuda, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Akihiro Itoh, Yoshiki Hirooka, Isao Nakano, Tetsuya Ishikawa, Fumihiro Urano, Kentaro Yoshioka, Hidenori Toyoda, Takashi Kumada, Yoshiaki Katano, Hidemi Goto, Effect of peginterferon alfa‐2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C Journal of Gastroenterology and Hepatology. ,vol. 30, pp. 321- 328 ,(2015) , 10.1111/JGH.12703
Fangfang Shi, Yamei Len, Yuping Gong, Rui Shi, Xi Yang, Duolan Naren, Tianyou Yan, Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia PLOS ONE. ,vol. 10, pp. e0136746- ,(2015) , 10.1371/JOURNAL.PONE.0136746
Katherine L. B. Borden, Biljana Culjkovic-Kraljacic, Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond? Leukemia & Lymphoma. ,vol. 51, pp. 1805- 1815 ,(2010) , 10.3109/10428194.2010.496506
Sébastien Vallée, Francis Fouchier, Diane Braguer, Jacques Marvaldi, Serge Champion, Ribavirin-induced resistance to heat shock, inhibition of the Ras-Raf-1 pathway and arrest in G1 European Journal of Pharmacology. ,vol. 404, pp. 49- 62 ,(2000) , 10.1016/S0014-2999(00)00596-3
Richard E. Kast, Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte function. Neoplasia. ,vol. 5, pp. 3- 8 ,(2003) , 10.1016/S1476-5586(03)80011-8
Laurent Volpon, Michael J. Osborne, Hiba Zahreddine, Andrea A. Romeo, Katherine L.B. Borden, Conformational changes induced in the eukaryotic translation initiation factor eIF4E by a clinically relevant inhibitor, ribavirin triphosphate Biochemical and Biophysical Research Communications. ,vol. 434, pp. 614- 619 ,(2013) , 10.1016/J.BBRC.2013.03.125
Yasukazu Yamada, Yutaka Natsumeda, George Weber, Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase. Biochemistry. ,vol. 27, pp. 2193- 2196 ,(1988) , 10.1021/BI00406A057
J. T. Witkowski, Roland K. Robins, Robert W. Sidwell, Lionel N. Simon, Design, synthesis, and broad spectrum antiviral activity of 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides Journal of Medicinal Chemistry. ,vol. 15, pp. 1150- 1154 ,(1972) , 10.1021/JM00281A014
Gulilat Gebeyehu, Victor E. Marquez, Anne Van Cott, David A. Cooney, James A. Kelley, Hiremagalur N. Jayaram, Gurpreet S. Ahluwalia, Robert L. Dion, Yvonne A. Wilson, David G. Johns, Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehydrogenase. Journal of Medicinal Chemistry. ,vol. 28, pp. 99- 105 ,(1985) , 10.1021/JM00379A018